Medtronic MiniMed recalls Paradigm MMT-712 and MMT-715 pumps due to potential insulin delivery issues during airplane take-off or landing, which could cause severe hypoglycemia or hyperglycemia. Affected users should contact Medtronic for guidance.
All Medtronic MiniMed pumps (Paradigm series, Minimed 530G, 6XX series, and 7XX series) were found to have the potential for abnormal insulin delivery due to changes in air pressure, which can be found during airplane take-off or landing. An unexpected additional dose of insulin, which can occur during take-off, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An unexpected under-delivery of insulin, which can occur during landing, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death. During a delivery accuracy dry run testing of the 780G NGP infusion pump under dynamic pressure conditions, the firm observed that when air pressure decreased during take-off simulation, on average 0.569U more insulin was delivered in 15 minutes than the expected delivery volume at ambient pressure at 1 U/hr delivery rate; when air pressure increased during landing simulation, on average 0.537 U less insulin was delivered in 25 minutes than the expected delivery volume at ambient pressure at 1 U/hr delivery rate. The firm also observed that the mechanisms causing the variations in delivery volumes are independent of the delivery rate.
Medtronic MiniMed is recalling Paradigm MMT-712 and MMT-715 insulin pumps because air pressure changes during airplane take-off or landing can cause unexpected insulin delivery or under-delivery. This may lead to severe hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), which can cause serious health issues or death.
The pumps can deliver extra insulin during take-off or less insulin during landing because of changes in air pressure. This can cause dangerous blood sugar levels, including severe hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar), which may lead to seizures, coma, or death.
People with diabetes who use Medtronic MiniMed Paradigm pumps (MMT-712 and MMT-715 models) are affected. Those traveling by air are at higher risk due to the pressure changes during take-off and landing.
Check if your pump has the model number MMT-712 or MMT-715. All lot numbers and unique device identifiers (UDIs) are affected. This recall covers all units sold by Medtronic MiniMed.
Reach out to Medtronic MiniMed for specific guidance on how to handle the recall, as they will provide instructions for affected users.
The pumps can deliver extra insulin during take-off or less insulin during landing due to air pressure changes, which may cause severe hypoglycemia or hyperglycemia.
Contact Medtronic MiniMed for specific guidance on how to handle the recall, as they will provide instructions for affected users.
Yes, the risk is higher during airplane take-off and landing due to air pressure changes.
We’ve drafted a message you can send Medtronic MiniMed to request your refund or repair — edit it as you like.
Subject: Recall Z-1255-2025 — Medtronic MiniMed Medtronic MiniMed Hello, I own a Medtronic MiniMed that is covered by recall Z-1255-2025 from Medtronic MiniMed. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
